Ametek (AME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
On September 16, 2026, we conducted a discounted cash flow (DCF) analysis for AMETEK Inc (AME), a company that has shown a price performance of +14.7% year-to-d
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.
AMETEK is well-positioned to capitalize on increased complexity across AI, semiconductor, aerospace, utilities, and medtech infrastructure. The $5B Indicor Instrumentation acquisition boosts aftermarket revenue, enhances earnings durability, and offers significant synergy potential with manageable integration risk. AME trades at a premium (~29x pre-acquisition guidance), justified by niche leadership, diversified end markets, strong cash flow, and a repeatable acquisition model.
BERWYN, Pa., Aug. 26, 2026 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced that it has completed its previously announced acquisition of a portfolio of instrumentation businesses from Indicor, LLC, ("Indicor Instrumentation") in an all‑cash transaction valued at $5.0 billion.
Ametek (AME) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.